Identifying novel drug indications through automated reasoning

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Tari, Luis ^a,d   Vo, Nguyen ^b   Liang, Shanshan ^b   Patel, Jagruti ^c   Baral, Chitta ^b   Cai, James ^a  

^a Disease and Translational Informatics   (United States)

^b Arizona State University   (United States)

^c Scientific Information Management   (United States)

^d GE GLOBAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIPYRIDAMOLE; ERLOTINIB; LEVODOPA; MOCLOBEMIDE; TAZAROTENE;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ARTIFICIAL INTELLIGENCE; AUTOMATED REASONING; AUTOMATION; CANCER INHIBITION; CELL PROLIFERATION; DEPRESSION; DRUG INDICATION; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; GENE TARGETING; KNOWLEDGE; LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; ONCOGENE; PARKINSON DISEASE; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

ARTIFICIAL INTELLIGENCE; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DATABASES, FACTUAL; DRUG DISCOVERY; GENETIC ASSOCIATION STUDIES; HUMANS; PROTEIN BINDING;

EID: 84864238297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040946     Document Type: Article

References (33)

1. DiMasi JA, Hansen RW, Grabowski HG, (2003) The price of innovation: new estimates of drug development costs. Journal of Health Economics 22: 151-185 doi:10.1016/S0167-6296(02)00126-1.
2. Ashburn TT, Thor KB, (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery 3: 673-683 doi:10.1038/nrd1468.
3. Ghofrani HA, Osterloh IH, Grimminger F, (2006) Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nature Reviews Drug Discovery 5: 689-702 doi:10.1038/nrd2030.
4. Dubus E, Ijjaali I, Barberan O, Petitet F, (2009) Drug repositioning using in silico compound profiling. Future Medicinal Chemistry 1: 1723-1736 doi:10.4155/fmc.09.123.
5. Deftereos SN, Andronis C, Friedla EJ, Persidis A, Persidis A, (2011) Drug repurposing and adverse event prediction using high-throughput literature analysis. Wiley Interdisciplinary Reviews Systems Biology and Medicine 3: 323-334 doi:10.1002/wsbm.147.
6. Arighi CN, Lu Z, Krallinger M, Cohen KB, Wilbur WJ, et al. (2011) Overview of the BioCreative III Workshop. BMC bioinformatics 12: S1 doi:10.1186/1471-2105-12-S8-S1.
7. Swanson DR, (1991) Complementary structures in disjoint science literatures. Proceedings of the 14th annual international ACM SIGIR conference on Research and Development in Information Retrieval pp. 280-289 doi:10.1145/122860.122889.
8. Weeber M, Vos R, Klein H, De Jong-Van Den Berg LTW, Aronson AR, et al. (2003) Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide. Journal of the American Medical Informatics Association 10: 252-259 doi:10.1197/jamia.M1158.
9. Yetisgen-Yildiz M, Pratt W, (2006) Using statistical and knowledge-based approaches for literature-based discovery. Journal of Biomedical informatics 39: 600-611 doi:10.1016/j.jbi.2005.11.010.
10. Kuhn M, Szklarczyk D, Franceschini A, Campillos M, von Mering C, et al. (2010) STITCH 2: an interaction network database for small molecules and proteins. Nucleic acids research 38: D552-6 doi:10.1093/nar/gkp937.
11. Taboureau O, Nielsen SK, Audouze K, Weinhold N, Edsgärd D, et al. (2011) ChemProt: a disease chemical biology database. Nucleic acids research 39: D367-72 doi:10.1093/nar/gkq906.
12. Ha S, Seo Y-J, Kwon M-S, Chang B-H, Han C-K, et al. (2008) IDMap: facilitating the detection of potential leads with therapeutic targets. Bioinformatics 24: 1413-1415 doi:10.1093/bioinformatics/btn138.
13. Andronis C, Sharma A, Virvilis V, Deftereos S, Persidis A, (2011) Literature mining, ontologies and information visualization for drug repurposing. Briefings in Bioinformatics 12: 357-368 doi:10.1093/bib/bbr005.
14. Lewitt PA, (2008) Levodopa for the treatment of Parkinson's disease. The New England Journal of Medicine 359: 2468-2476 doi:10.1056/NEJMct0800326.
15. Lo H-W, Hsu S-C, Hung M-C, (2006) EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Research and Treatment 95: 211-218 doi:10.1007/s10549-005-9011-0.
16. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, et al. (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic acids research 34: D668-72 doi:10.1093/nar/gkj067.
17. Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, et al. (2001) Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. The Pharmacogenomics Journal 1: 167-170.
18. Aranda B, Achuthan P, Alam-Faruque Y, Armean I, Bridge A, et al. (2010) The IntAct molecular interaction database in 2010. Nucleic Acids Research 38: D525-31 doi:10.1093/nar/gkp878.
19. Tari L, Tu PH, Hakenberg J, Chen Y, Son TC, et al. (2012) Incremental Information Extraction Using Relational Databases. IEEE Transactions on Knowledge and Data Engineering 24: 86-99 doi:10.1109/TKDE.2010.214.
20. Klein D, Manning CD, (2003) Accurate unlexicalized parsing. Proceedings of the 41st Annual Meeting on Association for Computational Linguistics (ACL'03). Vol. 1: 423-430 doi:10.3115/1075096.1075150.
21. Leaman R, Gonzalez G, (2008) BANNER: an executable survey of advances in biomedical named entity recognition. Pacific Symposium on Biocomputing pp. 652-663.
22. Hakenberg J, Plake C, Leaman R, Schroeder M, Gonzalez G, (2008) Inter-species normalization of gene mentions with GNAT. Bioinformatics 24: i126-132 doi:10.1093/bioinformatics/btn299.
23. Gelfond M, Lifschitz V, (1988) The Stable Model Semantics For Logic Programming. International Symposium on Logic Programming pp. 1070-1080.
24. Gelfond M, Lifschitz V, (1991) Classical Negation in Logic Programs and Disjunctive Databases. New Generation Computing pp. 365-387.
25. Baral C, (2003) Knowledge representation, reasoning and declarative problem solving. Cambridge University Press.
26. Gebser M, Ostrowski M, Schaub T, (2009) Constraint Answer Set Solving. Proceedings of the Twenty-fifth International Conference on Logic Programming (ICLP'09). Vol. 5649: 235-249 doi:10.1007/978-3-642-02846-5.
27. Phase I Study of Disulfiram, Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver, (2008) Available http://clinicaltrials.gov/ct2/show/NCT00742911.
28. Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer, Basal Cell Nevus Syndrome on the Chest, Back (2008) Available http://clinicaltrials.gov/ct2/show/NCT00783965.
29. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867 doi:10.1038/nature01322.
30. Bundschus M, Dejori M, Stetter M, Tresp V, Kriegel H-P, (2008) Extraction of semantic biomedical relations from text using conditional random fields. BMC Bioinformatics 9: 207 doi:10.1186/1471-2105-9-207.
31. Pyysalo S, Ginter F, Heimonen J, Björne J, Boberg J, et al. (2007) BioInfer: a corpus for information extraction in the biomedical domain. BMC Bioinformatics 8: 50 doi:10.1186/1471-2105-8-50.
32. Tari L, Anwar S, Liang S, Hakenberg J, Baral C, (2010) Synthesis of pharmacokinetic pathways through knowledge acquisition and automated reasoning. Pacific Symposium on Biocomputing. Vol. 476: 465-476.
33. Tari L, Anwar S, Liang S, Cai J, Baral C, (2010) Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics 26: i547-53 doi:10.1093/bioinformatics/btq382.